Navigation Links
China to "salvage" Reputation on Food, Drug Safety

China has announced fresh measures to ensure substandard drugs are stopped from reaching stores as it works to salvage its credibility following a raft of safety scandals, state press reported Thursday.

The nation's food and drug watchdog will have to abide by new regulations to improve transparency in the approval process of medicines and curb corruption within the industry, the China Daily reported.

"Transparency is the enemy of corruption. That's why we have introduced the new regulations," the paper cited the deputy chief of the State Food and Drug Administration, Wu Zhen, as saying.

Wu's comments came after the former head of the administration Zheng Xiaoyu was executed Tuesday following his conviction for bribe-taking to approve hundreds of medicines, some of which proved dangerous.

Zheng's case has come to symbolise the rampant graft and dishonesty in the country's product-safety systems which have raised alarm both in China and overseas.

The new regulations call for a panel of experts to approve new drugs, more transparent drug approval procedures, greater inspections of pharmaceutical factories and bigger fines for companies that flout the law, the paper said.

"In a renewed effort to ensure drug safety and salvage its credibility, China's drug watchdog announced revised methods... as part of the national crusade on restoring public confidence in the entire sector," the paper said in a separate editorial.

Despite such hopes, other Chinese officials were not so upbeat in the prospects of solving the problems.

"China is in a time of serious food safety risks and our task of fixing this is extremely arduous. Despite some recent improvements, the food safety outlook is no cause for optimism," Sun Xianze, head of the administration's food safety coordination department, said last week.


'"/>




Page: 1

Related medicine news :

1. China tells officials not to hide SARS damage
2. China reports declining number of SARS Cases
3. China says patient may have SARS
4. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
5. Adverse Effects Associated with Unauthorised Hepatitis A Vaccine in China
6. Pig Bacterium (Streptococcus suis) Kills 24 In China
7. Watch Out! Pollution hazard from E-waste recycling in India & China
8. French Fries In Cancer Controversy In China
9. China To Distribute Free Condoms To Combat AIDS/HIV
10. HIV Cases Steadily Increasing In China With The Toll Over 1.26 Lakh
11. India And China Discuss Import Of Encephalitis Vaccine

Post Your Comments:
(Date:12/2/2009)...ng medical device software engineering consulting ... certification. A relatively few medical device so...achieved ISO 13485 certification. Many medical dev... to other ISO standards as well. However, it is so...ing consulting firm to achieve the rigorous qualit...
(Date:12/2/2009)...Newswire/ -- A randomized, controlled study compar...nvasive treatment called percutaneous disc decompr...ile both treatments help patients in the short run...up to two years later. Results of the study, the f...al meeting of the Radiological Society of North Am...
(Date:12/2/2009)...asound of suspicious areas of the breast, includin...ternative to invasive biopsies for women under age...ented today at the annual meeting of the Radiologi...rming high-quality breast ultrasound, we can reduc...iagnostic procedures in young women," said senior ...
(Date:12/1/2009)...ate Christ Medical Center in Oak Lawn, Ill. has be...nter and the first for Chicago’s south and s... hospital’s plans today (December 1) by the ...rd. , Springfield, Ill. (...Lawn, Ill. has become the state’s newest kid...
(Date:12/1/2009)...c. 1 Reportlinker.com announces th...s catalogue: ,, The Future of Monoclonal Antib...hmarking, Product Pipeline and Deals Analysis ,...e-of-Monoclonal-Antibodies---Market-Forecasts-to-2...Deals-Analysis.html ,, Summary ,, The au...
Breaking Medicine News(10 mins):Health News:Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 3Health News:Targeted breast ultrasound can reduce biopsies for women under 40 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 3Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13
...ect of hormone replacement therapy may be inhibite...eroidal anti-inflammatory pain killer, report rese...f Pennsylvania. The researchers examined t...coronary heart disease and compared them with 7,00...
...ople another reason to quit smoking, by finding th...oping depression in comparison to those who never...kers who have quit have an elevated risk of depres... style and successful smoking cessation in long ru...
...that vegetarian diet reduces risk of colon cancer ...up as appetizer reduces food intake by about 20 pe...ife factors like choosing your diet regimen or ord...t to find out whether a vegetarian diet is associa...
...lthcare scenario has emerged a heartening developm...ated Paromomycin IM injection manufactured by the...fit drug firm, for inclusion in its Model List for...rasitic disease after malaria. It is a sy...
...ests using gene sequencing is able to help confirm...ns and patients the tools for much more accurate ...e a group of more than 40 inherited and potentiall...ucts that damage organs and tissues. The g...
...t men with chronic gum disease periodontitis, may ...ss of whether they smoke. Periodontitis is...a, though recent evidence suggests the involvement... Roswell Park Cancer Institute, Buffalo. A...
Other Medicine News:Health News:Regular Smokers are at the Risk of Developing Depression 2Health News:Vegetarian Diet Could Reduce Risk of Colon Cancer 2Health News:Vegetarian Diet Could Reduce Risk of Colon Cancer 3Health News:Vegetarian Diet Could Reduce Risk of Colon Cancer 4Health News:A Non-profit Drug Firms Injection to Fight Kala Azar Included in WHOs Model List 2Health News:A Non-profit Drug Firms Injection to Fight Kala Azar Included in WHOs Model List 3Health News:New DNA Tests Advances Treatment of Lysosomal Storage Diseases 2Health News:Men With Chronic Gum Disease at Higher Risk of Tongue Cancer 2
(Date:12/1/2009)..., BELLEVUE, Wash., Dec. 1 /PRNewswire-FirstCall/...g online retailer of health, beauty, vision, and p...y was its best day ever as customer orders were th...the drugstore.com and Beauty.com web stores fe...and their largest gift selection yet. ,, (Logo:...
(Date:12/1/2009)..., NEW YORK, Dec. 1 Reportlinker.... available in its catalogue: ,, Direct to Cons...t and Future Market Outlook, Regulatory Landscape ...om/p0166813/Direct-to-Consumer-DTC-Advertising-in-...k-Regulatory-Landscape-and-Case-Studies.html ,...
(Date:12/1/2009)...ologist reports 90 percent radiation reduction in ...-USNewswire/ -- Dr. James Earls, a radiologist fro...hington, D.C. will present the findings of a study...f radiation heart patients received from CT scans ... Dr. Earls will present the study to the annual me...
Breaking Medicine Technology:drugstore.com, inc. Has Best Day Ever on Cyber Monday 2drugstore.com, inc. Has Best Day Ever on Cyber Monday 3Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 2Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 3Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 4Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 5Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 6Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 7Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 8Radiation Reduction in Heart CT Scans Reported in Study 2EGEN Inc Announces the Promotion of Khursheed Anwer Ph D to President and Chief Scientific Officer 12452 1EGEN Inc Announces the Promotion of Khursheed Anwer Ph D to President and Chief Scientific Officer 12452 2GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Global Brands 47821 1GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Global Brands 47821 2Small molecules mimic natural gene regulators 8713 1Small molecules mimic natural gene regulators 8713 2
...ne payment to Pharmasset , , PRINCETON, N.J., Apr...e (Roche SWX: RO, ROG; Pink Sheets: RHHBY) today a...a Phase IIb study of R7128, the nucleoside polymer... treatment of chronic hepatitis C (HCV). The trial...of R7128 in combination with Roche,s PEGASYS(R) (p...
...for Blinatumomab , , NEW YORK, April 24 Micromet...any developing novel, proprietary antibodies for t...e diseases, today held an R&D Day for investor...ork City. , , The presentations highlighted sig...TE antibody platform and included updates on: , ,...
Other Medicine Technology:Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 2Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 3Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 4Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 5Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 6Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 7Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 8Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 9Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 10Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 2Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 3Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 4
PulseOx 7500 Pulse Oximeter
Merlin Patient Care System
Safire Bi-directional Ablation Catheter
VASOVIEW® HemoPro™ Endoscopic Vessel Harvesting System
Medicine Products: